First Time Loading...
V

Vifor Pharma AG
SIX:VIFN

Watchlist Manager
Vifor Pharma AG
SIX:VIFN
Watchlist
Price: 166.15 CHF 0.48% Market Closed
Updated: May 3, 2024

Wall Street
Price Targets

VIFN Price Targets Summary
Vifor Pharma AG

Wall Street analysts forecast VIFN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for VIFN is 167 CHF .

Lowest
Price Target
Not Available
Average
Price Target
167 CHF
1% Upside
Highest
Price Target
Not Available
Vifor Pharma AG Competitors:
Price Targets
GLAXO
GlaxoSmithKline Pharmaceuticals Ltd
2% Downside
GRIN
Grown Rogue International Inc
29% Downside
600789
Shandong Lukang Pharmaceutical Co Ltd
72% Upside
4746
Formosa Laboratories Inc
38% Upside
VRCA
Verrica Pharmaceuticals Inc
96% Upside
4530
Hisamitsu Pharmaceutical Co Inc
8% Upside
MRK
Merck KGaA
24% Upside

Revenue
Forecast

Revenue Estimate
Vifor Pharma AG

For the last 8 years the compound annual growth rate for Vifor Pharma AG's revenue is -8%. The projected CAGR for the next 3 years is 11%.

-8%
Past Growth
11%
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Vifor Pharma AG

For the last 8 years the compound annual growth rate for Vifor Pharma AG's operating income is -1%. The projected CAGR for the next 3 years is 16%.

-1%
Past Growth
16%
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Net Income
Forecast

Net Income Estimate
Vifor Pharma AG

For the last 8 years the compound annual growth rate for Vifor Pharma AG's net income is -9%. The projected CAGR for the next 3 years is 31%.

-9%
Past Growth
31%
Estimated Growth
Estimates Accuracy
-3%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is VIFN's stock price target?
Price Target
167 CHF

According to Wall Street analysts, the average 1-year price target for VIFN is 167 CHF .

What is Vifor Pharma AG's Revenue forecast?
Projected CAGR
11%

For the last 8 years the compound annual growth rate for Vifor Pharma AG's revenue is -8%. The projected CAGR for the next 3 years is 11%.

What is Vifor Pharma AG's Operating Income forecast?
Projected CAGR
16%

For the last 8 years the compound annual growth rate for Vifor Pharma AG's operating income is -1%. The projected CAGR for the next 3 years is 16%.

What is Vifor Pharma AG's Net Income forecast?
Projected CAGR
31%

For the last 8 years the compound annual growth rate for Vifor Pharma AG's net income is -9%. The projected CAGR for the next 3 years is 31%.